Zhang, R., Ma, J., Avery, J. T., Sambandam, V., Nguyen, T. H., Xu, B., . . . Boohaker, R. J. (2020). GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAF(V600E) Colorectal Cancer. Front Oncol.
Dyfyniad Arddull ChicagoZhang, Ruowen, Jinlu Ma, Justin T. Avery, Vijaya Sambandam, Theresa H. Nguyen, Bo Xu, Mark J. Suto, and Rebecca J. Boohaker. "GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance By Downregulating NBS1 Transcription in BRAF(V600E) Colorectal Cancer." Front Oncol 2020.
Dyfyniad MLAZhang, Ruowen, et al. "GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance By Downregulating NBS1 Transcription in BRAF(V600E) Colorectal Cancer." Front Oncol 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.